Pharmacotherapy of obstructive sleep apnea

Bibliography

• Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39
   PubMed Web of Science ®Google Scholar
• Krieger J. Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep 1992;15(6 Suppl):S42-6
   PubMed Web of Science ®Google Scholar
• Lacassagne L, Didier A, Doussau S, Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index. Rev Mal Respir 2000;17:467-74
   PubMed Web of Science ®Google Scholar
• Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008;5:173-8
   PubMedGoogle Scholar
• Ferguson KA, Cartwright R, Rogers R, Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006;29:244-62
   PubMed Web of Science ®Google Scholar
• Kushida CA, Morgenthaler TI, Littner MR, Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for 2005. Sleep 2006;29:240-3
   PubMed Web of Science ®Google Scholar
• Veasey SC, Guilleminault C, Strohl KP, Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006;29:1036-44
   PubMed Web of Science ®Google Scholar
• Morgenthaler TI, Kapen S, Lee-Chiong T, Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 2006;29:1031-5
   PubMed Web of Science ®Google Scholar
• Wellman A, Jordan AS, Malhotra A, Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:1225-32
   PubMed Web of Science ®Google Scholar
• Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull Eur Physiopathol Respir 1983;19:632-4
   PubMedGoogle Scholar
• Orth MM, Grootoonk S, Duchna HW, Short-term effects of oral theophylline in addition to CPAP in mild to moderate OSAS. Respir Med 2005;99:471-6
   PubMed Web of Science ®Google Scholar
• Atkinson RL, Suratt PM, Wilhoit SC, Naloxone improves sleep apnea in obese humans. Int J Obes 1985;9:233-9
   PubMed Web of Science ®Google Scholar
• Greenberg HE, Rapoport DM, Rothenberg SA, Endogenous opiates modulate the postapnea ventilatory response in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1991;143:1282-7
   PubMedGoogle Scholar
• Benarroch EE. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord 2007;22:155-61
   PubMed Web of Science ®Google Scholar
• Guilleminault C, Cao M, Yue HJ, Obstructive sleep apnea and chronic opioid use. Lung 2010;188:459-68
   PubMed Web of Science ®Google Scholar
• Suratt PM, Wilhoit SC, Brown ED, Effect of doxapram on obstructive sleep apnea. Bull Eur Physiopathol Respir 1986;22:127-31
   PubMedGoogle Scholar
• Quitadamo C, Fabbretti E, Lamanauskas N, Activation and desensitization of neuronal nicotinic receptors modulate glutamatergic transmission on neonatal rat hypoglossal motoneurons. Eur J Neurosci 2005;22:2723-34
   PubMed Web of Science ®Google Scholar
• Haxhiu MA, Van Lunteren E, Van de Graaff WB, Action of nicotine on the respiratory activity of the diaphragm and genioglossus muscles and the nerves that innervate them. Respir Physiol 1984;57:153-69
   PubMedGoogle Scholar
• Haxhiu MA, Deal EC Jr, Norcia MP, Medullary effects of nicotine and GABA on tracheal smooth muscle tone. Respir Physiol 1986;64:351-63
   PubMedGoogle Scholar
• Davila DG, Hurt RD, Offord KP, Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994;150:469-74
   PubMed Web of Science ®Google Scholar
• Zevin S, Swed E, Cahan C. Clinical effects of locally delivered nicotine in obstructive sleep apnea syndrome. Am J Ther 2003;10:170-5
   PubMedGoogle Scholar
• Chamberlin NL, Saper CB. Topographic organization of respiratory responses to glutamate microstimulation of the parabrachial nucleus in the rat. J Neurosci 1994;14:6500-10
   PubMed Web of Science ®Google Scholar
• Hedner J, Grunstein R, Eriksson B, A double-blind, randomized trial of sabeluzole – a putative glutamate antagonist – in obstructive sleep apnea. Sleep 1996;19:287-9
   PubMed Web of Science ®Google Scholar
• Finnimore AJ, Roebuck M, Sajkov D, The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995;8:230-4
   PubMed Web of Science ®Google Scholar
• Torvaldsson S, Grote L, Peker Y, A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathing. J Sleep Res 2005;14:149-55
   PubMed Web of Science ®Google Scholar
• Whyte KF, Gould GA, Airlie MA, Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988;11:463-72
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Nakazawa Y, Hashizume Y, Effects of acetazolamide on the sleep apnea syndrome and its therapeutic mechanism. Psychiatry Clin Neurosci 1995;49:59-64
   PubMed Web of Science ®Google Scholar
• Inoue Y, Takata K, Sakamoto I, Clinical efficacy and indication of acetazolamide treatment on sleep apnea syndrome. Psychiatry Clin Neurosci 1999;53:321-2
   PubMed Web of Science ®Google Scholar
• Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006;173:234-7
   PubMed Web of Science ®Google Scholar
• Nussbaumer-Ochsner Y, Latshang TD, Ulrich S, Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial. Chest 2012;141(1):131-38
   PubMed Web of Science ®Google Scholar
• Hedner J, Kraiczi H, Peker Y, Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003;168:1246-51
   PubMed Web of Science ®Google Scholar
• Moraes W, Poyares D, Sukys-Claudino L, Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest 2008;133:677-83
   PubMed Web of Science ®Google Scholar
• Susky-Soranos L, Moraes W, Guilleminault C, Beneficial effect of donepezil on obstructive sleep apnea: a double blind placebo controlled clinical trial. Sleep medicine 2012;13(3):290-96
   PubMed Web of Science ®Google Scholar
• Veasey SC. Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med 2003;2:21-9
   PubMedGoogle Scholar
• Veasey SC, Zhan G, Fenik P, Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output. Am J Respir Crit Care Med 2004;170:665-72
   PubMed Web of Science ®Google Scholar
• Kraiczi H, Hedner J, Dahlof P, Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 1999;22:61-7
   PubMed Web of Science ®Google Scholar
• Berry RB, Yamaura EM, Gill K, Acute effects of paroxetine on genioglossus activity in obstructive sleep apnea. Sleep 1999;22:1087-92
   PubMed Web of Science ®Google Scholar
• Prasad B, Radulovacki M, Olopade C, Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. Sleep 2010;33:982-9
   PubMed Web of Science ®Google Scholar
• Brownell LG, Perez-Padilla R, West P, The role of protriptyline in obstructive sleep apnea. Bull Eur Physiopathol Respir 1983;19:621-4
   PubMedGoogle Scholar
• Smith PL, Haponik EF, Allen RP, The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983;127:8-13
   PubMed Web of Science ®Google Scholar
• Berry RB, Koch GL, Hayward LF. Low-dose mirtazapine increases genioglossus activity in the anesthetized rat. Sleep 2005;28:78-84
   PubMed Web of Science ®Google Scholar
• Castillo JL, Menendez P, Segovia L, Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS). Sleep Med 2004;5:507-8
   PubMed Web of Science ®Google Scholar
• Brunner H. Success and failure of mirtazapine as alternative treatment in elderly stroke patients with sleep apnea-a preliminary open trial. Sleep Breath 2008;12:281-5
   PubMed Web of Science ®Google Scholar
• Marshall NS, Yee BJ, Desai AV, Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. Sleep 2008;31:824-31
   PubMed Web of Science ®Google Scholar
• Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992;145:435-9
   PubMed Web of Science ®Google Scholar
• Pawlik MT, Hansen E, Waldhauser D, Clonidine premedication in patients with sleep apnea syndrome: a randomized, double-blind, placebo-controlled study. Anesth Analg 2005;101:1374-80
   PubMed Web of Science ®Google Scholar
• Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991;115:527-32
   PubMed Web of Science ®Google Scholar
• Weiss V, Sonka K, Pretl M, Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 2000;23:515-19
   PubMed Web of Science ®Google Scholar
• Mestron A, Webb SM, Astorga R, Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the spanish acromegaly registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 2004;151:439-46
   PubMed Web of Science ®Google Scholar
• Herrmann BL, Wessendorf TE, Ajaj W, Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 2004;151:309-15
   PubMed Web of Science ®Google Scholar
• Ip MS, Tan KC, Peh WC, Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 2001;55:477-83
   PubMed Web of Science ®Google Scholar
• Rosenow F, Reuter S, Deuss U, Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 1996;45:563-9
   PubMed Web of Science ®Google Scholar
• Winkelman JW, Goldman H, Piscatelli N, Are thyroid function tests necessary in patients with suspected sleep apnea? Sleep 1996;19:790-3
   PubMed Web of Science ®Google Scholar
• Resta O, Pannacciulli N, Di Gioia G, High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 2004;14:248-53
   PubMed Web of Science ®Google Scholar
• Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism. Chest 1992;102:1663-7
   PubMed Web of Science ®Google Scholar
• Grunstein RR, Sullivan CE. Sleep apnea and hypothyroidism: mechanisms and management. Am J Med 1988;85:775-9
   PubMed Web of Science ®Google Scholar
• Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med 1999;160:732-5
   PubMed Web of Science ®Google Scholar
• Rowley JA, Zhou XS, Diamond MP, The determinants of the apnea threshold during NREM sleep in normal subjects. Sleep 2006;29:95-103
   PubMed Web of Science ®Google Scholar
• Young T, Finn L, Austin D, Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003;167:1181-5
   PubMed Web of Science ®Google Scholar
• Pickett CK, Regensteiner JG, Woodard WD, Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989;66:1656-61
   PubMed Web of Science ®Google Scholar
• Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999;6:196-200
   PubMed Web of Science ®Google Scholar
• Manber R, Kuo TF, Cataldo N, The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003;26:163-8
   PubMed Web of Science ®Google Scholar
• Saletu-Zyhlarz G, Anderer P, Gruber G, Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003;12:239-54
   PubMed Web of Science ®Google Scholar
• Cistulli PA, Barnes DJ, Grunstein RR, Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994;49:699-702
   PubMed Web of Science ®Google Scholar
• Block AJ, Wynne JW, Boysen PG, Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981;70:506-10
   PubMed Web of Science ®Google Scholar
• Polo-Kantola P, Rauhala E, Helenius H, Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol 2003;102:68-75
   PubMed Web of Science ®Google Scholar
• Nelson HD, Humphrey LL, Nygren P, Postmenopausal hormone replacement therapy: scientific review. JAMA 2002;288:872-81
   PubMed Web of Science ®Google Scholar
• Terra SG, Oberg KC. Medroxyprogesterone acetate in the treatment of obstructive sleep apnea. Ann Pharmacother 1997;31:776-8
   PubMed Web of Science ®Google Scholar
• Stewart DA, Grunstein RR, Berthon-Jones M, Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 1992;146:1389-93
   PubMed Web of Science ®Google Scholar
• Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest 2003;26:493-8
   PubMed Web of Science ®Google Scholar
• Liu PY, Yee B, Wishart SM, The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003;88:3605-13
   PubMed Web of Science ®Google Scholar
• Canova CR, Downs SH, Knoblauch A, Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration 2004;71:138-43
   PubMed Web of Science ®Google Scholar
• Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 2004;59:50-5
   PubMed Web of Science ®Google Scholar
• Alexopoulos EI, Kaditis AG, Kalampouka E, Nasal corticosteroids for children with snoring. Pediatr Pulmonol 2004;38:161-7
   PubMed Web of Science ®Google Scholar
• Mansfield LE, Diaz G, Posey CR, Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol 2004;92:240-4
   PubMed Web of Science ®Google Scholar
• Goldbart AD, Goldman JL, Veling MC, Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005;172:364-70
   PubMed Web of Science ®Google Scholar
• Dayyat E, Serpero LD, Kheirandish-Gozal L, Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 2009;135:1142-9
   PubMed Web of Science ®Google Scholar
• Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics 2006;117:e61-6
   PubMed Web of Science ®Google Scholar
• Braver HM, Block AJ. Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep 1994;17:516-21
   PubMed Web of Science ®Google Scholar
• Guilleminault C, Philip P. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 1996;19(9 Suppl):S117-22
   PubMed Web of Science ®Google Scholar
• Weaver TE, Maislin G, Dinges DF, Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-19
   PubMed Web of Science ®Google Scholar
• Hedner J, Zou D. Pharmacological management of sleep-disordered breathing. In: McNicholas WT, Bonsignore MR, editors. Sleep Apnoea. 50 European Respiratory Monograph; UK: 2010. p. 321-39
   Google Scholar
• Hirshkowitz M, Black JE, Wesnes K, Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007;101:616-27
   PubMed Web of Science ®Google Scholar
• Roth T, White D, Schmidt-Nowara W, Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006;28:689-706
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Papanicolaou DA, Bixler EO, Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-16
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Zoumakis E, Lin HM, Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409-13
   PubMed Web of Science ®Google Scholar
• Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58:87-114
   PubMed Web of Science ®Google Scholar
• El Solh AA, Saliba R, Bosinski T, Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006;27:997-1002
   PubMed Web of Science ®Google Scholar
• Grebe M, Eisele HJ, Weissmann N, Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006;173:897-901
   PubMed Web of Science ®Google Scholar
• Gonzaga CC, Gaddam KK, Ahmed MI, Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clin Sleep Med 2010;6:363-8
   PubMed Web of Science ®Google Scholar
• Gaddam K, Pimenta E, Thomas SJ, Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010;24:532-7
   PubMed Web of Science ®Google Scholar
• Ozol D, Turkay C, Kasapoglu B, Relationship between components of metabolic syndrome and polysomnographic findings in obstructive sleep apnea. Metab Syndr Relat Disord 2011;9:13-18
   PubMed Web of Science ®Google Scholar
• Trombetta IC, Somers VK, Maki-Nunes C, Consequences of comorbid sleep apnea in the metabolic syndrome – implications for cardiovascular risk. Sleep 2010;33:1193-9
   PubMed Web of Science ®Google Scholar
• Lam JC, Mak JC, Ip MS. Obesity, obstructive sleep apnea and metabolic syndrome. Respirology 2011;17(2):223-36
   Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21
   PubMed Web of Science ®Google Scholar
• Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2003;4:CD004094
   Google Scholar
• Camacho ME, Morin CM. The effect of temazepam on respiration in elderly insomniacs with mild sleep apnea. Sleep 1995;18:644-5
   PubMed Web of Science ®Google Scholar
• Berry RB, Kouchi K, Bower J, Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:450-4
   PubMed Web of Science ®Google Scholar
• Schneider H, Grote L, Peter JH, The effect of triazolam and flunitrazepam – two benzodiazepines with different half-lives – on breathing during sleep. Chest 1996;109:909-15
   PubMed Web of Science ®Google Scholar
• Abad VC, Guilleminault C. Pharmacological treatment of obstructive sleep apnea. Curr Pharm Des 2011;17:1418-25
   PubMed Web of Science ®Google Scholar
• Farney RJ, Walker JM, Cloward TV, Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003;123:632-9
   PubMed Web of Science ®Google Scholar
• Wang D, Teichtahl H, Drummer O, Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005;128:1348-56
   PubMed Web of Science ®Google Scholar
• Gross JB, Bachenberg KL, Benumof JL, Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006;104(5):1081-93
   PubMed Web of Science ®Google Scholar
• Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg 2008;107:1543-63
   PubMed Web of Science ®Google Scholar
• Schwengel DA, Sterni LM, Tunkel DE, Perioperative management of children with obstructive sleep apnea. Anesth Analg 2009;109:60-75
   PubMed Web of Science ®Google Scholar